Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cholestin trademark suit

This article was originally published in The Tan Sheet

Executive Summary

Filed April 14 by Simi Valley, Calif.-based Pharmanex in Salt Lake City, Utah federal court. Lawsuit seeks an injunction against HPF, Inc.' s marketing of Cholestene, a red yeast rice product for healthy cholesterol. Pharmanex argues the product is deceptively similar to Cholestin, which generated sales of more than $3.5 mil. in 1998, according to the firm. Cholestene was launched in health food and mass market stores by Trevose, Penn.-based HPF in January ("The Tan Sheet" April 12, In Brief). Pharmanex also is sending letters to approximately 4,500 independent pharmacists pointing out differences between the two products, including Cholestin's production through a proprietary process using a particular strain of red yeast rice. The firm believes no other red yeast rice product uses the strain found in Cholestin and that HPF's use of clinical studies conducted by Pharmanex is "therefore unwarranted." Cholestin is marketed through direct sales and in some independent pharmacies

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts